Non-muscle Invasive Bladder Cancer
📧 Sign up to get email alerts when something new happens for Non-muscle Invasive Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-09-08Clinical Trial Update: Pilot Study to Evaluate the Clinical Response to Mitomycin-C in Hydrogel (TC-3) Administered Intravesically in NMIBC Patients [NA]
A pilot study evaluating the clinical response to intravesical Mitomycin-C in a hydrogel formulation (TC-3) for non-muscle invasive bladder …
-
FDA approval · 2016-07-29FDA Approved: CYSVIEW — Supplemental Application (Photocure Inc.)
The FDA has approved a supplemental application for CYSVIEW (HEXAMINOLEVULINATE HYDROCHLORIDE) from Photocure Inc.
-
CLINICAL_TRIALS trial_result · 2016-07-28Clinical Trial Update: Mycobacterial Cell Wall-DNA Complex in Treatment of BCG-refractory Patients With Non-muscle Invasive Bladder Cancer [Phase 2, Phase 3]
A completed Phase 2/Phase 3 trial evaluated the Mycobacterial Cell Wall-DNA Complex in patients with non-muscle invasive bladder cancer that…
-
CLINICAL_TRIALS research · 2016-03-24Clinical Trial Update: Transurethral Resection of Bladder Tumor (TURBT) Combined With Adjuvant Intravenous GC Chemotherapy for Non-muscle-invasive Bladder Cancer [NA]
A clinical trial update describes a study of transurethral resection of bladder tumor followed by adjuvant intravenous gemcitabine/cisplatin…
-
CLINICAL_TRIALS trial_result · 2015-12-18Clinical Trial Update: Genetic Susceptibility to Tumor Recurrence and Progression in Patients With Non-Muscle Invasive Bladder Cancer
A completed study investigating whether genetic factors influence recurrence and progression in non-muscle invasive bladder cancer.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-11-20Clinical Trial Update: Mitomycin C Versus Bacillus Calmette-Guerin in the Intravesical Treatment of Non-Muscle-Invasive Bladder Cancer Patients [Phase 3]
A Phase 3 trial comparing intravesical mitomycin C with Bacillus Calmette-Guerin for non-muscle-invasive bladder cancer was terminated, with…
-
CLINICAL_TRIALS withdrawal · 2015-09-01Clinical Trial Update: A Prospective Open Label Comparative Dose Ranging Study Evaluating the Effect of Pre-TURBT Intravesical Instillation of Mitomycin C (MMC) Mixed With TC-3 Gel in Patients With Non Muscle Invasive Bladder Cancer (NMIBC) [NA]
Clinical trial update indicates that a prospective open-label dose-ranging study of pre-TURBT intravesical mitomycin C mixed with TC-3 Gel f…
-
CLINICAL_TRIALS research · 2015-05-14Clinical Trial Update: Comparison of Medical and Surgical Treatments of Benign Prostate Hyperplasia in Patients Who Have Low Grade Non Muscle Invasive Bladder Cancer for Tumour Recurrence and Progression [Phase 4]
Phase 4 clinical trial comparing medical versus surgical treatment options for benign prostatic hyperplasia in patients with low-grade non-m…
-
CLINICAL_TRIALS trial_result · 2015-05-06Clinical Trial Update: Maximum Tolerable Concentration of abnobaVISCUM Fraxini Intravesically in Patients With Superficial Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating the maximum tolerable intravesical concentration of abnobaVISCUM Fraxini in patients with superficial bladder c…
-
CLINICAL_TRIALS trial_result · 2015-02-10Clinical Trial Update: Study With TMX-101 in Patients With Carcinoma In Situ (CIS) Bladder Cancer [Phase 2]
Phase 2 study evaluating TMX-101 for carcinoma in situ of the bladder and non-muscle-invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-01-22Clinical Trial Update: Celecoxib for the Treatment of Non-muscle Invasive Bladder Cancer [Phase 2]
A Phase 2 trial evaluating celecoxib for non-muscle invasive bladder cancer has completed.
-
CLINICAL_TRIALS trial_result · 2014-10-22Clinical Trial Update: Multi-center Study to Evaluate the Efficacy and Safety of Maintenance Therapy With Valrubicin Versus no Maintenance, in Subjects Treated With Valrubicin Induction for Carcinoma in Situ (CIS) of the Bladder [Phase 3]
A Phase 3 trial evaluating maintenance valrubicin versus no maintenance after valrubicin induction in bladder carcinoma in situ; study termi…
-
CLINICAL_TRIALS trial_result · 2014-09-11Clinical Trial Update: Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial comparing EN3348 (mycobacterial cell wall-DNA complex) to mitomycin C for intravesical treatment of BCG-recurrent/refractory n…
-
CLINICAL_TRIALS withdrawal · 2014-08-29Clinical Trial Update: First Line Comparative Study of EN3348 (MCC) vs BCG in NMIBC [Phase 3]
A Phase 3 trial comparing EN3348 (MCC) with BCG for non-muscle invasive bladder cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2014-08-25Clinical Trial Update: Effectiveness of Hexaminolevulinate (Hexvix) in the Diagnosis and Treatment of Patients With Non-invasive Bladder Cancer
Clinical trial results update on the effectiveness of Hexaminolevulinate (Hexvix) for diagnosing and treating non-muscle invasive bladder ca…
-
CLINICAL_TRIALS trial_result · 2013-10-11Clinical Trial Update: A Randomized, Comparative Study of Hexvix Fluorescence Cystoscopy and Standard Cystoscopy in Patients With Non-invasive Bladder Cancer [Phase 3]
Phase 3 randomized trial comparing Hexvix fluorescence cystoscopy to standard cystoscopy in non-muscle invasive bladder cancer. Results were…
-
CLINICAL_TRIALS trial_result · 2013-08-21Clinical Trial Update: Phase 2b, Trial of Intravesical DTA-H19/PEI in Patients With Intermediate-Risk Superficial Bladder Cancer [Phase 2]
Phase 2b trial update for intravesical DTA-H19/PEI in intermediate-risk superficial bladder cancer has completed with results posted in 2013…
-
CLINICAL_TRIALS trial_result · 2013-08-09Clinical Trial Update: Intravesical Adjuvant Electromotive Mitomycin-C [Phase 2, Phase 3]
Clinical trial update announcing completion of Phase 2/3 evaluation of intravesical adjuvant electromotive delivery of mitomycin-C for bladd…
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: Cis-urocanic Acid (Cis-UCA) in Patients With Primary or Recurrent Non-muscle Invasive Bladder Cancer [Phase 1]
Phase 1 clinical trial update for Cis-urocanic acid (Cis-UCA) in patients with primary or recurrent non-muscle invasive bladder cancer; stud…
-
CLINICAL_TRIALS research · 2012-10-26Clinical Trial Update: Sequential Whole Bladder Photodynamic Therapy (WBPDT) in the Management of Superficial Bladder Cancer [Phase 1, Phase 2]
This clinical trial update reports completion of Phase 1/2 study of Sequential Whole Bladder Photodynamic Therapy for superficial bladder ca…
-
CLINICAL_TRIALS trial_result · 2011-10-04Clinical Trial Update: Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer [Phase 3]
Phase 3 trial of preoperative intravesical electromotive mitomycin-C for primary non-muscle invasive bladder cancer has completed.
-
CLINICAL_TRIALS research · 2011-03-24Clinical Trial Update: Study of the Efficacy of Maintenance Therapy Using Uracil-tegafur (UFT) or Bacille Calmette-Guerin (BCG) for the Prevention of Recurrences of Superficial Bladder Cancer (EMBARK Study) [Phase 3]
This is a Phase 3 clinical trial evaluating maintenance therapy with Uracil-tegafur (UFT) or Bacillus Calmette-Guérin (BCG) to prevent recur…
-
CLINICAL_TRIALS trial_result · 2011-03-04Clinical Trial Update: Combined Use of BCG and Interferon Alpha in Bladder Cancer [Phase 2, Phase 3]
A completed Phase 2/3 clinical trial evaluating the combination of Bacillus Calmette-Guérin (BCG) and Interferon Alpha for superficial bladd…
-
CLINICAL_TRIALS trial_result · 2010-02-08Clinical Trial Update: Study of Immediate Post-Operative Intravesical Instillation of Chemophase® in Patients With Superficial Bladder Cancer [Phase 1]
Phase 1 study evaluating immediate post-operative intravesical instillation of Chemophase in patients with non-muscle-invasive bladder cance…
-
CLINICAL_TRIALS research · 2009-02-17Clinical Trial Update: Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection [Phase 2, Phase 3]
The trial compares distilled water to mitomycin C for preventing recurrence after transurethral resection of recurrent superficial bladder c…